Hiroshi Ureshino

43PUBLICATIONS
35CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical mycologyInnate immunityRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Aug 12, 2026
Do FLT3 and KIR3DL1 converge on a common immune surveillance axis in treatment-free remission of chronic myeloid leukemia?

|May 29, 2026
Clonal dynamics and therapeutic pressure in myeloproliferative neoplasm with concomitant chronic myeloid leukemia: Potential implications of JAK2-directed therapy and additional mutations.

|May 28, 2026
Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.

|May 11, 2026
Dynamic improvement of the treatment-free remission prognostic score by prolonging MR4 duration in chronic myeloid leukaemia.

|Mar 18, 2026
Potential impact of NK-cell education on interferon efficacy in the ENDURE trial.

Mai Fujita, Hiroshi Ureshino

|Feb 02, 2026
Peripheral Blood Neutrophil Maturation as a Practical Predictor of Treatment-Free Remission in CML.

Mai Fujita, Hiroshi Ureshino, Shinya Kimura

Pageof 8

Frequent Collaborators

6 joint publications

Shinya Kimura

4 joint publications

Kazuharu Kamachi

3 joint publications

Tatsuro Watanabe

3 joint publications

Nao Yoshida-Sakai